Company Badge
USPTO Data Jan 1 1976 - Dec 9 2025
6 Patents
#132 in South San Francisco, CA
#10,283 in California
#43,751 in US
Vaxart, Inc.
Forward Citations = 5
12 inventors:
South San Francisco, CA, United States of America
Vaxart, Inc.
CIPO Patents = 5
EPO Patents = 4
Trademarks = 3
Forward Citations = 5
Loading Chart...
Loading Chart...
12 inventors (with patents filed for the assignee):
Sean Tucker (5 out of 49 patents)
George Robert Trager (2 out of 5 patents)
Ciaran Daniel Scallan (2 out of 8 patents)
4. Leesun Kim (2 out of 2 patents)
5. Delphine Compere (1 out of 8 patents)
6. Marta Blumenfeld (1 out of 38 patents)
7. Jean-Michel Gauthier (1 out of 4 patents)
8. Sean N Tucker (0 patent)
9. Richard K Plemper (0 patent)
10. Elyse Bourque (0 patent)
11. Eddy Lee (0 patent)
12. John Vernachio (0 patent)
6 patents:
1. 12186407 - Formulations for small intestinal delivery of RSV and norovirus antigens (2025-01-07),
Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant vaccines. The company utilizes its proprietary oral vaccine platform to create vaccines for a variety of infectious diseases. Vaxart's lead vaccine candidates target influenza, norovirus, and respiratory syncytial virus. By delivering vaccines orally, Vaxart aims to improve vaccine efficacy and compliance. Founded in 2004 and headquartered in South San Francisco, Vaxart is committed to revolutionizing the field of vaccine development.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
5 patents (CIPO):
Please report any incorrect information to support@idiyas.com
4 patents (EPO):
Please report any incorrect information to support@idiyas.com